Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma TransitionCarlos R. Gil Del Alcazar, Kornélia Polyák, Sung Jin Huh et al.|Cancer Discovery|2017Cited by 242
Genomic Alterations during the <i>In Situ</i> to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune SystemAnne Trinh, Kornélia Polyák, Carlos R. Gil Del Alcazar et al.|Molecular Cancer Research|2020Cited by 38
A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK)Min Ho Park, Joon Jeong, Byung-In Moon et al.|The Breast|2020Cited by 2